Evaluation of Thailand national external quality assessment on HIV testing

International Journal of Health Care Quality Assurance - 2007
WilaiChalermchan1, SirpornPitak1, SuwaneeSungkawasee1
1National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand

Tóm tắt

PurposeThe Thailand National Institute of Health (NIH) established an external quality assessment (EQA) scheme on HIV serology testing since 1994 for many public health laboratories. For the past six years, the NIH has evaluated the activities of 226 laboratories.Design/methodology/approachApproximately 40,000 tests using 16 trial samples of external quality assessment panel performed at 226 laboratories during 2000‐2006. The methods performed were classified into five assays; machine‐based enzyme immunoassay (MBA), microplate‐based enzyme immunoassay (EIA), simple/rapid test and antigen assay only performed at blood screening laboratory centers. A few laboratories performed confirmation method by western blot (WB). Most participating laboratories performed at least two methods.FindingsThe evaluation showed that, during the six‐year period, the program had an increasing response rate among all groups of laboratories: government hospital laboratories, private hospital and clinic laboratories and blood screening laboratory centers. Moreover, there were no significantly different errors found between these groups. The highest median percent of overall errors found was in antigen assay. Very minimal errors appeared on other methods.Originality/valueNational HIV EQA program has played an important role in improving the quality of participating laboratory performance. The participating laboratories gained a better understanding and were able to use good quality anti‐HIV approved kits. Furthermore, HIV serology testing selection was varied over the past six years as microplate‐based EIA was mostly used in the past but currently MBA and simple/rapid test are more commonly used. The test methods were determined by test volumes and budget. In addition, sensitivity was one critical reason labs chose to use EIA. The most popular method used was simple/rapid testing. Overall errors occurred with all assays but not with WB. Errors could occur with any test techniques if good quality management is not employed.

Từ khóa


Tài liệu tham khảo

Bureau of AIDAS, TB, and STIs (BATS) (2000), National Guidelines for the Clinical Management of HIV Infection in Children and Adults, Bureau of AIDAS, TB, and STIs, Bangkok.

Constantine, N.T. (2005), Retroviral Testing and Quality Assurance, University of Maryland, Baltimore, MD.

ISO (1996), Guide 43‐1:Proficiency Testing by Inter‐laboratory Comparison: Part 1: Development and Operation of Proficiency Testing Scheme, International Organization for Standardization, Geneva.

Kumari, S. and Bhatia, R. (2003), “Quality assurance in bacteriology and immunology: guidelines for peripheral and intermediate laboratories”, WHO Regional Publication, South‐East Asia Series, Vol. 28, World Health Organization, New Delhi, pp. 57‐73.

NCCLS (1991), Approved Guideline: Human Immunodeficiency Virus Type 1 Reference Material Specification, NCCLS Document I/LA 13‐A, Vol. 11, Clinical and Laboratory Standards Institute, Wayne, PA.

Snell, J., Brown, D. and Robert, C. (2000), Quality Assurance: Principle and Practice in the Microbiology Laboratory, Public Health Laboratory Service, London, pp. 77‐90.

Thompson, M. and Wood, R. (1993), “International harmonised protocol for proficiency testing of (chemical) analytical laboratories”, JAOAC International, Vol. 76 No. 4, pp. 926‐40.

WHO (2003), WHO Treat 3 Million by 2005: Rapid HIV Tests: Guidelines for Use in HIV Testing and Counselling Services in Resources‐Constrained Settings, World Health Organization, Geneva, p. 23.

WHO/UNAIDS (1996), Guidelines for Organizing National External Quality Assessment Schemes for HIV Serology Testing, WHO/UNAIDS/96.5, Geneva.

WHO/UNAIDS (2001), Guidelines for Using HIV Testing Technologies in Surveillance: Selection, Evaluation and Implementation, WHO/UNAIDS, Geneva.

WHO/UNAIDS (2002), HIV Simple/Rapid Assays Operational Characteristics (Phase I) Report 12, WHO/UNAIDS, Geneva.

Thông tin
Thông tin xuất bản

International Journal of Health Care Quality Assurance

Thông tin tác giả